⌘K

Login Start Free

Home/Filings/4/0001415889-23-002555

4//SEC Filing

Amin Naseem 4

Accession 0001415889-23-002555

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 7:32 PM ET

Size

4.6 KB

Accession

0001415889-23-002555

Insider Transaction Report

Form 4

Period: 2023-02-10

Bellerophon Therapeutics, Inc.BLPH

Director

Transactions

Award
Common Stock
2023-02-10+84,000→ 244,287 total

Footnotes (1)

[F1]RSAs fully vested on grant date.

Documents

1 file

4
form4-02152023_120207.xmlPrimary

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001646754

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 7:32 PM ET
Size: 4.6 KB

View on SEC.gov